Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome

por Naume, B, Sørlie, T
Publicado 2005

ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

por Kyte, J. A., Røssevold, A., Falk, R. S., Naume, B.
Publicado 2020

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer

por Kyte, J. A., Andresen, N. K., Russnes, H. G., Fretland, S. Ø., Falk, R. S., Lingjærde, O. C., Naume, B.
Publicado 2020

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

por Fangberget, A., Nilsen, L. B., Hole, K. H., Holmen, M. M., Engebraaten, O., Naume, B., Smith, H.-J., Olsen, D. R., Seierstad, T.
Publicado 2010

Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors

por Baumbusch, LO, Aarøe, J, Johansen, FE, Hicks, J, Sun, H, Bruhn, L, Gunderson, K, Naume, B, Kristensen, VN, Liestøl, K, Børresen-Dale, A-L, Lingjærde, OC
Publicado 2008